United States· US:69842-474_47491cc4-1a60-464e-e063-6394a90a2770
CVS Gentle Tears
A medicinal product containing hypromellose, unspecified; dextran 70, registered in United States by CVS Pharmacy, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- HYPROMELLOSE, UNSPECIFIED; DEXTRAN 70
- Manufacturer
- CVS Pharmacy, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc11698424740135 VIAL, SINGLE-USE in 1 BOX (69842-474-01) / .4 mL in 1 VIAL, SINGLE-USE
- ndc1169842-474-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hypromellose, unspecified; dextran 70 in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomTears Naturale eye dropsAlcon Eye Care UK Ltd
- CanadaTEARS NATURALE FREEALCON CANADA INC
- SwedenTears Naturale 3 mg/ml + 1 mg/ml Ögondroppar, lösningAlcon Nordic A/S
- SpainDACROLUX 3MG/ML +1MG/ML COLIRIO EN SOLUCIÓNReva Health Europe S.L.
- NorwayTears NaturaleAlcon Nordic A/S
Authorised across Europe · EMA
The same active substance is authorised in 9 EEA countries. Names it is sold under:
- Belgium · Augverz
- Bulgaria · Тиърс Натурале Іі
- Cyprus · Tearprol
- Greece · Tearprol
- Luxembourg · Augverz
- Netherlands · Duratears
- Norway · Tears Naturale
- Sweden · Tears Naturale
- Slovenia · Tears Naturale Ii
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d3d9e6a4-020b-4f04-badb-5cf7b04f5c28 GET /v1/drugs/d3d9e6a4-020b-4f04-badb-5cf7b04f5c28?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": ".3; .1",
"substance": "HYPROMELLOSE, UNSPECIFIED; DEXTRAN 70",
"productndc": "69842-474",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "g/100mL; g/100mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about hypromellose, unspecified; dextran 70.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.